Riskpilot← Back to searchSign inGet full accessASTRAZENECA AS
ASActiveOrg 918209999Karvesvingen 7, 0579 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 1979105 employeeswww.astrazeneca.com
Revenue 2024
NOK 907,6M
+21% vs 2023
EBITDA margin
2.6%
0% vs 2023
Equity ratio
70.5%
Financial strength
Net profit 2024
NOK 28,5M
+9% vs 2023
| Revenue | NOK 907,6M | +21% |
| EBITDA | NOK 23,3M | +0% |
| Net profit | NOK 28,5M | +9% |
| Total assets | NOK 602,5M | +17% |
| Equity | NOK 424,6M | +7% |
| Employees | 105 | — |
Legal name
ASTRAZENECA AS
Org number
918209999
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
29. mai 1979
Share capital
NOK 115 050 000
Employees
105 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap eller styrets leder alene.
Company purpose
Handel med medisinske, farmasøytiske, veterinæriske produkter og spesialiteter samt tilhørende virksomhet, herunder deltagelse i foretak med lignende virksomhet.
Address
Karvesvingen 7, 0579 Oslo
Website
www.astrazeneca.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2009 | 2010 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 33 357 000 | 901 248 | 627 262 | 561 334 | 610 954 | 653 634 | 616 921 | 564 033 | 519 842 | 487 239 | 584 970 | 557 726 | 646 378 | 749 561 | 907 643 |
| Staff expenses | −202 118 | −105 767 | −60 444 | −65 490 | −73 502 | −84 766 | −54 477 | −43 175 | −63 176 | −57 432 | −69 756 | −73 293 | −94 030 | −0 | −0 |
| EBITDA | 11 555 966 | 49 794 | 28 591 | 43 093 | 2 489 | 30 341 | 40 826 | 22 828 | 20 967 | 20 707 | 15 970 | 14 439 | 20 857 | 23 404 | 23 311 |
| Depreciation & amort. | −12 966 | −884 | −852 | −517 | −517 | −258 | −40 | −153 | −153 | −141 | −0 | −0 | −167 | −244 | −375 |
| EBIT | 11 543 000 | 48 910 | 27 739 | 42 576 | 1 972 | 30 083 | 40 786 | 22 675 | 20 814 | 20 567 | 15 970 | 14 439 | 20 690 | 23 160 | 22 936 |
| Net financials | −736 000 | 5 144 | 5 995 | 4 866 | 5 977 | 767 | 1 506 | 1 272 | 1 944 | 3 346 | 1 433 | 359 | 5 077 | 12 825 | 17 770 |
| Profit before tax | 10 807 000 | 54 054 | 33 734 | 47 442 | 7 949 | 30 850 | 42 292 | 23 947 | 22 758 | 23 913 | 17 403 | 14 798 | 25 767 | 35 985 | 40 706 |
| Tax | 3 263 000 | 19 769 | 11 936 | 14 867 | 3 015 | 9 522 | 10 987 | 6 464 | 5 884 | 6 373 | 4 452 | 3 986 | 7 395 | −0 | −0 |
| Net profit | 7 544 000 | 34 285 | 21 798 | 32 576 | 4 933 | 21 328 | 31 305 | 17 483 | 16 874 | 17 540 | 12 951 | 10 812 | 18 373 | 26 245 | 28 491 |
| Item | 2009 | 2010 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 54 920 000 | 479 437 | 448 724 | 478 951 | 329 114 | 342 413 | 375 827 | 397 207 | 422 236 | 396 404 | 457 016 | 423 518 | 475 240 | 513 470 | 602 474 |
| Equity | 20 821 000 | 280 074 | 337 049 | 219 625 | 221 633 | 244 304 | 275 609 | 294 900 | 311 774 | 329 552 | 340 442 | 352 450 | 372 705 | 398 031 | 424 609 |
| Long-term debt | 12 628 000 | −25 265 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 17 640 000 | 174 098 | 89 223 | 241 329 | 90 930 | 84 384 | 90 102 | 99 456 | 107 967 | 64 996 | 112 420 | 68 787 | 102 535 | 114 679 | 177 865 |
| Total debt | 30 268 000 | 174 098 | 89 223 | 241 329 | 90 930 | 84 384 | 90 102 | 99 456 | 107 967 | 64 996 | 112 420 | 68 787 | 102 535 | 114 679 | 177 865 |
EBITDA margin
2.6%
This company
15.8%
Market median
-84% vs market
20092024
Equity ratio
70.5%
This company
38.2%
Market median
+85% vs market
20092024
Return on equity
6.7%
This company
18.4%
Market median
-64% vs market
20092024
Net profit margin
3.1%
This company
8.1%
Market median
-62% vs market
20092024
Asset turnover
1.51×
This company
1.12×
Market median
+35% vs market
20092024
Debt / equity
0.42×
This company
0.62×
Market median
+32% vs market
20092024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
GB Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
CJ Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2023 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Astrazeneca Continent B.V | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ASTRAZENECA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Guro Bjøntegaard | Chief Executive Officer | 0 companies |
| Christof Josef Bischoff | Chief Executive Officer | 0 companies |
| Emelie Karin Susanne Antoni | Chairman | 0 companies |
| Lars-Johan Cederbrant | Board of Directors | 0 companies |
| Kristin Janett Løseth | Board of Directors | 0 companies |
| Erik Jesper Bergkvist | Board of Directors | 0 companies |
| Kerstin Anna-Lena Engvall | Chairman | 0 companies |
| Anna Margaretha Scott | Board of Directors | 0 companies |
| Kurt Hungeberg | Board of Directors | 0 companies |